Keyphrases
Acute Myeloid Leukemia
100%
Prognostic Value
100%
Transcriptome Analysis
100%
V-domain Ig Suppressor of T Cell Activation
100%
Leukemia Patients
50%
Working Diagnosis
25%
Recurrent Disease
25%
Leukemia Cell Lines
25%
NPM1 mutation
25%
Whole Exome Sequencing
12%
T Cells
12%
MRNA Level
12%
Disease Onset
12%
Leukemia Cells
12%
Bone Marrow
12%
Healthy Individuals
12%
Leukemia
12%
Hematopoietic Stem Cells
12%
Myeloid Differentiation
12%
Strong Correlation
12%
Conventional Chemotherapy
12%
Expression Level
12%
Negative Regulator
12%
Treatment Resistance
12%
Myelomonocytic
12%
Publicly Available
12%
Chemotherapy Regimen
12%
Myeloid Malignancies
12%
FMS-like Tyrosine Kinase 3 (FLT3)
12%
Acute Myeloid Leukemia Cells
12%
Disease Treatment
12%
Single-cell RNA Sequencing (scRNA-seq)
12%
Immune Escape
12%
Antitumor Immune Response
12%
Targeted Therapeutics
12%
Normal Karyotype
12%
Normal Hematopoiesis
12%
Immune Parameters
12%
Current Diagnostics
12%
Pharmacological Targets
12%
Long-term Remission
12%
Diagnostic Scheme
12%
Monocytic Differentiation
12%
Immune Checkpoint Regulator
12%
Medicine and Dentistry
Gene Expression Profiling
100%
T Cell Activation
100%
Acute Myeloid Leukemia
100%
Immunoglobulin Domain
100%
Immunity
37%
Recurrent Disease
25%
NPM1
25%
Diagnosis
12%
RNA Sequence
12%
Immune Response
12%
Immunotherapy
12%
Leukemia Cell
12%
Combination Therapy
12%
T Cell
12%
Myeloid Differentiation
12%
Hematopoiesis
12%
Myeloid Malignancy
12%
Leukemia
12%
Exome Sequencing
12%
Pharmacological Target
12%
Leukemia Cell Line
12%
Karyotype
12%
Acute Myeloid Leukemia Cell Line
12%
Chemotherapy
12%
Messenger RNA
12%
Hematopoietic Cell
12%
Diseases
12%
Immunology and Microbiology
T Cell Activation
100%
Myeloid
100%
Immunoglobulin Domain
100%
Gene Expression Assay
100%
Immunity
22%
Hematopoietic Cell
11%
T Cell
11%
Immune Response
11%
Myeloid Differentiation
11%
Immunotherapy
11%
RNA Sequence
11%
Leukemia Cell
11%
Whole Exome Sequencing
11%
Hematopoiesis
11%
Immune Escape
11%
Leukemia Cell Line
11%
mRNA Expression Level
11%
Karyotype
11%
Acute Myeloid Leukemia Cell Line
11%